Literature DB >> 10788570

Characterization of the period of sensitivity of fetal male sexual development to vinclozolin.

C J Wolf1, G A LeBlanc, J S Ostby, L E Gray.   

Abstract

Vinclozolin is a fungicide whose metabolites are androgen receptor (AR) antagonists. Previous work in our laboratory showed that perinatal administration of vinclozolin to rats results in malformations of the external genitalia, permanent nipples, reduced anogenital distance (AGD), and reduced seminal vesicle, ventral prostate, and epididymal weights. The objectives of this study were to determine the most sensitive period of fetal development to antiandrogenic effects of vinclozolin and to identify a dosing regime that would induce malformations in all of the male offspring. Pregnant rats were dosed with 400 mg vinclozolin/kg/day on either GD 12-13, GD 14-15, GD 16-17, GD 18-19, or GD 20-21, or with corn oil (2.5 ml/kg) from GD 12 through GD 21 (Experiment 1). All 2-day periods in which significant effects were produced were included in an extended dosing period, GD 14 through GD 19, in which pregnant rats were dosed with 200 or 400 mg vinclozolin/kg (Experiment 2). In Experiment 1, significant effects of vinclozolin were observed in rats dosed on gestation days (GD) 14-15, GD 16-17, and GD 18-19, while the most significant effects were observed in rats treated on GD 16-17. These effects include reduced AGD; presence of areolas, nipples, and malformations of the phallus; and reduced levator ani/bulbocavernosus weight. In contrast, ventral prostate weight was reduced only in the GD 18-19 group. The expanded dosing regime (Experiment 2) increased the percentage of male offspring with genital malformations (> 92%), and retained nipples (100%), further reduced the weight of the ventral prostate, and reduced the weight of the seminal vesicles. In addition, malformations were more severe and included vaginal pouch and ectopic/undescended testes. The latter was induced only in the 400 mg/kg group. These data indicate that the reproductive system of the fetal male rat is most sensitive to antiandrogenic effects of vinclozolin on GD 16 and 17, although effects are more severe and 100 % of male offspring are affected with administration of vinclozolin from GD 14 through GD 19.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10788570     DOI: 10.1093/toxsci/55.1.152

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  29 in total

1.  Effects of prenatal exposure to a low dose atrazine metabolite mixture on pubertal timing and prostate development of male Long-Evans rats.

Authors:  Jason P Stanko; Rolondo R Enoch; Jennifer L Rayner; Christine C Davis; Douglas C Wolf; David E Malarkey; Suzanne E Fenton
Journal:  Reprod Toxicol       Date:  2010-08-19       Impact factor: 3.143

2.  Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease.

Authors:  Matthew D Anway; Charles Leathers; Michael K Skinner
Journal:  Endocrinology       Date:  2006-09-14       Impact factor: 4.736

3.  Serum organochlorine pesticide residues and risk of testicular germ cell carcinoma: a population-based case-control study.

Authors:  Mary L Biggs; Mark D Davis; David L Eaton; Noel S Weiss; Dana B Barr; David R Doody; Sherianne Fish; Larry L Needham; Chu Chen; Stephen M Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

4.  Effects of endocrine disruptors on prosobranch snails (Mollusca: Gastropoda) in the laboratory. Part III: Cyproterone acetate and vinclozolin as antiandrogens.

Authors:  M Tillmann; U Schulte-Oehlmann; M Duft; B Markert; J Oehlmann
Journal:  Ecotoxicology       Date:  2001-12       Impact factor: 2.823

5.  A Conflicted Tale of Two Novel AR Antagonists In Vitro and In Vivo: Pyrifluquinazon Versus Bisphenol C.

Authors:  Leon Earl Gray; Johnathan R Furr; Justin M Conley; Christy S Lambright; Nicola Evans; Mary C Cardon; Vickie S Wilson; Paul M Foster; Phillip C Hartig
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

6.  Vinclozolin exposure in utero induces postpubertal prostatitis and reduces sperm production via a reversible hormone-regulated mechanism.

Authors:  Prue A Cowin; Elspeth Gold; Jasna Aleksova; Moira K O'Bryan; Paul M D Foster; Hamish S Scott; Gail P Risbridger
Journal:  Endocrinology       Date:  2010-01-07       Impact factor: 4.736

Review 7.  Endocrine disruptors and Leydig cell function.

Authors:  K Svechnikov; G Izzo; L Landreh; J Weisser; O Söder
Journal:  J Biomed Biotechnol       Date:  2010-08-25

8.  Timing of androgen receptor disruption and estrogen exposure underlies a spectrum of congenital penile anomalies.

Authors:  Zhengui Zheng; Brooke A Armfield; Martin J Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

9.  Epigenetic transgenerational inheritance of vinclozolin induced mouse adult onset disease and associated sperm epigenome biomarkers.

Authors:  Carlos Guerrero-Bosagna; Trevor R Covert; Md M Haque; Matthew Settles; Eric E Nilsson; Matthew D Anway; Michael K Skinner
Journal:  Reprod Toxicol       Date:  2012-10-02       Impact factor: 3.143

10.  Long-term effects of environmental endocrine disruptors on reproductive physiology and behavior.

Authors:  Heather B Patisaul; Heather B Adewale
Journal:  Front Behav Neurosci       Date:  2009-06-29       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.